<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2018 [PPXK5GW761L0VLLJM56S]. www.edgarsuite.com -->
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:468pt><P align=center style='font:10pt Times New Roman;margin:0'><B>UNITED STATES</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>SECURITIES AND EXCHANGE COMMISSION</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Washington, D. C. 20549</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>FORM 8-K</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>CURRENT REPORT</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Pursuant to Section 13 Or 15(d) of the</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Securities Exchange Act of 1934</B></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>Date of Report (Date of earliest event reported): September 21, 2018 </P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:12pt Times New Roman;margin:0'><FONT style='font-size:12pt;border-bottom:1px solid #000000'><B>GB Sciences, Inc.</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Exact name of Registrant as specified in its charter)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>Delaware</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(State or other Jurisdiction of <BR>Incorporation or organization)</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>000-55462</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Commission File Number)</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>59-3733133</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(IRS Employer I.D. No.)</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>3550 W. Teco Avenue</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Las Vegas, Nevada 89118  </B></P>
<P align=center style='font:10pt Times New Roman;margin:0'><B>Phone: (844) 843-2569</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Address, including zip code, and telephone number, including area code, of</P>
<P align=center style='font:10pt Times New Roman;margin:0'>registrant&#8217;s principal executive offices)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style='border-bottom:1px solid #000000'><B>N/A</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>(Former name, former address and former fiscal year, if changed since last report)</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:8pt Times New Roman;margin:0'>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </P>
<P style='font:8pt Times New Roman;margin:0'> &nbsp;</P>
<P style='font:8pt Times New Roman;margin:0'><KBD style='position:absolute;font:8pt Times New Roman;margin-left:0pt'><FONT style='font-family:Segoe UI Symbol'>&#9744;</FONT> </KBD><KBD style='position:absolute;font:8pt Times New Roman;margin-left:36pt'> </KBD><KBD style=margin-left:72pt></KBD>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)&nbsp;</P>
<P style='font:8pt Times New Roman;margin:0'><KBD style='position:absolute;font:8pt Times New Roman;margin-left:0pt'> </KBD><KBD style='position:absolute;font:8pt Times New Roman;margin-left:36pt'> </KBD><KBD style=margin-left:72pt></KBD> &nbsp;</P>
<P style='font:8pt Times New Roman;margin:0'><KBD style='position:absolute;font:8pt Times New Roman;margin-left:0pt'><FONT style='font-family:Segoe UI Symbol'>&#9744;</FONT> </KBD><KBD style='position:absolute;font:8pt Times New Roman;margin-left:36pt'> </KBD><KBD style=margin-left:72pt></KBD>Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 2)&nbsp;</P>
<P style='font:8pt Times New Roman;margin:0'><KBD style='position:absolute;font:8pt Times New Roman;margin-left:0pt'> </KBD><KBD style='position:absolute;font:8pt Times New Roman;margin-left:36pt'> </KBD><KBD style=margin-left:72pt></KBD> &nbsp;</P>
<P style='font:8pt Times New Roman;margin:0'><KBD style='position:absolute;font:8pt Times New Roman;margin-left:0pt'><FONT style='font-family:Segoe UI Symbol'>&#9744;</FONT> </KBD><KBD style='position:absolute;font:8pt Times New Roman;margin-left:36pt'> </KBD><KBD style=margin-left:72pt></KBD>Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))&nbsp;</P>
<P style='font:8pt Times New Roman;margin:0'><KBD style='position:absolute;font:8pt Times New Roman;margin-left:0pt'> </KBD><KBD style='position:absolute;font:8pt Times New Roman;margin-left:36pt'> </KBD><KBD style=margin-left:72pt></KBD> &nbsp;</P>
<P style='font:8pt Times New Roman;margin:0'><KBD style='position:absolute;font:8pt Times New Roman;margin-left:0pt'><FONT style='font-family:Segoe UI Symbol'>&#9744;</FONT> </KBD><KBD style='position:absolute;font:8pt Times New Roman;margin-left:36pt'> </KBD><KBD style=margin-left:72pt></KBD>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'><FONT style=font-size:10pt><B>ITEM 3.02  Unregistered Sales of Equity Securities.</B></FONT></P>
<P style='font:11pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;color:#000000;background-color:#FFFFFF'><FONT style=font-size:10pt>The Registrant has issued a total of 16,482,000 shares of common stock (the &quot;Shares&quot;) to a total of fourteen entities or individuals in exchange for $4,120,500. &nbsp;The issuance was exempt from the registration requirements of Section 5 of the Securities Act of 1933 pursuant to Section 4(2) of the same Act and Rule 506 promulgated thereunder since the issuance of the Shares did not involve any public offering. &nbsp;</FONT></P>
<P style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P style='font:11pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>SIGNATURE PAGE</B></FONT></P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>
<P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=3 valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;  &nbsp;  &nbsp;&nbsp;GB Sciences, Inc.</B></FONT></P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Dated: September 21, 2018</FONT></P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>By: </FONT></P>
</TD><TD valign=top style='border-bottom:1.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'><FONT style=font-size:10pt>/s/ Ksenia Griswold</FONT></P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'><FONT style=font-size:10pt>Ksenia Griswold</FONT></P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0;margin-left:18pt'><FONT style=font-size:10pt>Chief Financial Officer </FONT></P>
</TD><TD valign=middle><P style='font:11pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;width:0;margin:15pt 0 0 0'><P align=center style='font:10pt Calibri;margin:0'>1</P>
<P style='font:11pt Calibri;margin:0'>&nbsp;</P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "gblx_8k.htm", "description": "8-K", "secsgml_size_bytes": 10402}]
{"company-data": {"conformed-name": "GB SCIENCES INC", "cik": "0001165320", "assigned-sic": "1311", "irs-number": "593733133", "state-of-incorporation": "DE", "fiscal-year-end": "0331"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-55462", "film-number": "181082267"}, "business-address": {"street1": "6450 CAMERON STREET #110A", "city": "LAS VEGAS", "state": "NV", "zip": "89118", "phone": "(844) 843-2569"}, "mail-address": {"street1": "6450 CAMERON STREET #110A", "city": "LAS VEGAS", "state": "NV", "zip": "89118"}, "former-company": [{"former-conformed-name": "Growblox Sciences, Inc.", "date-changed": "20140603"}, {"former-conformed-name": "Signature Exploration & Production Corp.", "date-changed": "20080602"}, {"former-conformed-name": "Diabetic Treatment Centers of America, Inc.", "date-changed": "20040812"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 Or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 21, 2018
GB Sciences, Inc.
(Exact name of Registrant as specified in its charter)
Delaware
(State or other Jurisdiction of
Incorporation or organization)
000-55462
(Commission File Number)
59-3733133
(IRS Employer I.D. No.)
3550 W. Teco Avenue
Las Vegas, Nevada 89118
Phone: (844) 843-2569
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 2)
☐
Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))
ITEM 3.02  Unregistered Sales of Equity Securities.
The Registrant has issued a total of 16,482,000 shares of common stock (the "Shares") to a total of fourteen entities or individuals in exchange for $4,120,500.  The issuance was exempt from the registration requirements of Section 5 of the Securities Act of 1933 pursuant to Section 4(2) of the same Act and Rule 506 promulgated thereunder since the issuance of the Shares did not involve any public offering.
SIGNATURE PAGE
Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GB Sciences, Inc.
Dated: September 21, 2018
By:
/s/ Ksenia Griswold
Ksenia Griswold
Chief Financial Officer
1